Home/Filings/4/0001437749-11-007941
4//SEC Filing

Khosrovi Behzad 4

Accession 0001437749-11-007941

CIK 0001389545other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 6:26 PM ET

Size

5.3 KB

Accession

0001437749-11-007941

Insider Transaction Report

Form 4
Period: 2011-10-27
Khosrovi Behzad
VP Research and Development
Transactions
  • Award

    Option (right to buy)

    2011-10-27+70,000434,200 total
    Exercise: $1.09From: 2012-10-27Exp: 2021-10-27Common Shares (70,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the option shares vest and become exercisable on the first anniversary of the date of grant, and the balance of the option shares vest and become exercisable in a series of twelve (12) equal installments upon the completion of each three (3) months beginning October 27, 2012.

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001410078

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:26 PM ET
Size
5.3 KB